Karyopharm Therapeutics, Inc. (KPTI)
8.58
-0.36
(-4.03%)
USD |
NASDAQ |
Feb 13, 16:00
8.60
+0.02
(+0.23%)
Pre-Market: 20:00
Karyopharm Therapeutics Profit Margin (Quarterly) : -299.9% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Baxter International, Inc. | -34.80% |
| Bruker Corp. | 2.99% |
| Catalyst Pharmaceuticals, Inc. | 35.57% |
| Agios Pharmaceuticals, Inc. | -541.1% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -162.9% |
| Gross Profit Margin (Quarterly) | 95.65% |
| Operating Margin (Quarterly) | -52.36% |
| Return on Net Operating Assets | -457.2% |